Long-term renal and pancreas function with tacrolimus rescue therapy following kidney/pancreas transplantation

Transplant Proc. 1997 Feb-Mar;29(1-2):652-3. doi: 10.1016/s0041-1345(96)00381-8.

Authors

S Hariharan¹, V R Peddi, R Munda, A M Demmy, T J Schroeder, J W Alexander, M R First

Affiliation

¹ Department of Internal Medicine, University of Cincinnati Medical Center, Ohio, USA.

PMID: 9123462
DOI: 10.1016/s0041-1345(96)00381-8

No abstract available

MeSH terms

Adult
Arterioles / pathology
Blood Glucose / metabolism
Creatinine / blood
Cyclosporine / adverse effects*
Female
Follow-Up Studies
Glycated Hemoglobin / analysis
Graft Rejection / epidemiology
Graft Rejection / therapy
Graft Survival
Humans
Immunosuppressive Agents / adverse effects
Immunosuppressive Agents / therapeutic use*
Kidney Transplantation / immunology
Kidney Transplantation / pathology
Kidney Transplantation / physiology*
Male
Middle Aged
Muromonab-CD3 / therapeutic use
Pancreas Transplantation / immunology
Pancreas Transplantation / pathology
Pancreas Transplantation / physiology*
Postoperative Complications
Tacrolimus / therapeutic use*
Time Factors

Substances

Blood Glucose
Glycated Hemoglobin A
Immunosuppressive Agents
Muromonab-CD3
Cyclosporine
Creatinine
Tacrolimus